In our toxicity analysis of cisplatin, which is a drug that targets dividing cells, in HT-29 heterospheroids, we noted that the fibroblast population appeared more sensitive to the drug than the HT-29 cancer cells, because they lost the expression of the proliferation marker Ki67. Here, MKI67 is linked to cancer.